{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:06:47Z","timestamp":1793390807961,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-026-03454-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:04:57Z","timestamp":1780049097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perioperative glucagon-like peptide-1 receptor agonist use and surgical outcomes in patients with morbid obesity (BMI\u2009&gt;\u200935) undergoing robotic urologic surgery: A propensity score-matched analysis"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3678-638X","authenticated-orcid":false,"given":"Michael","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Mirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-8452","authenticated-orcid":false,"given":"Michael","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"3454_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ajcnut.2025.04.023","volume":"122","author":"D Mozaffarian","year":"2025","unstructured":"Mozaffarian D, Agarwal M, Aggarwal M et al (2025) Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr 122:344\u2013367. https:\/\/doi.org\/10.1016\/j.ajcnut.2025.04.023","journal-title":"Am J Clin Nutr"},{"key":"3454_CR2","doi-asserted-by":"publisher","first-page":"e2540890","DOI":"10.1001\/jamanetworkopen.2025.40890","volume":"8","author":"P Li","year":"2025","unstructured":"Li P, Varghese JS, Shah MK et al (2025) Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity. JAMA Netw Open 8:e2540890. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.40890","journal-title":"JAMA Netw Open"},{"key":"3454_CR3","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.37765\/ajmc.2025.89778","volume":"31","author":"M Ukhanova","year":"2025","unstructured":"Ukhanova M, Wozny JS, Truong CN et al (2025) Trends in glucagon-like peptide 1 receptor agonist prescribing patterns. Am J Manag Care 31:e228\u2013e234. https:\/\/doi.org\/10.37765\/ajmc.2025.89778","journal-title":"Am J Manag Care"},{"key":"3454_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.26817","author":"NK DeCleene","year":"2026","unstructured":"DeCleene NK, Kahn E, Yuan C-W et al (2026) US state-level prevalence of adult obesity by race and ethnicity from 1990 to 2022 and forecasted to 2035. JAMA. https:\/\/doi.org\/10.1001\/jama.2025.26817","journal-title":"JAMA"},{"key":"3454_CR5","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc26-S001","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes* (2026) 1. Improving care and promoting health in populations: Standards of care in diabetes-2026. Diabetes Care 49:S13\u2013S26. https:\/\/doi.org\/10.2337\/dc26-S001","journal-title":"Diabetes Care"},{"key":"3454_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.urology.2016.11.028","volume":"100","author":"SC Johnson","year":"2017","unstructured":"Johnson SC, Packiam VT, Golan S et al (2017) The effect of obesity on perioperative outcomes for open and minimally invasive prostatectomy. Urology 100:111\u2013116. https:\/\/doi.org\/10.1016\/j.urology.2016.11.028","journal-title":"Urology"},{"key":"3454_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.urology.2016.06.018","volume":"96","author":"MD Grimes","year":"2016","unstructured":"Grimes MD, Blute ML Jr, Wittmann TA et al (2016) A critical analysis of perioperative outcomes in morbidly obese patients following renal mass surgery. Urology 96:93\u201398. https:\/\/doi.org\/10.1016\/j.urology.2016.06.018","journal-title":"Urology"},{"key":"3454_CR8","doi-asserted-by":"publisher","first-page":"576e11","DOI":"10.1016\/j.urolonc.2019.06.006","volume":"37","author":"M Nayan","year":"2019","unstructured":"Nayan M, Jalali S, Kapoor A et al (2019) Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis. Urol Oncol 37:576e11\u2013576e16. https:\/\/doi.org\/10.1016\/j.urolonc.2019.06.006","journal-title":"Urol Oncol"},{"key":"3454_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.urology.2024.07.052","volume":"194","author":"JM Flores","year":"2024","unstructured":"Flores JM, Thorogood S, Jenkins LC et al (2024) Does diabetes have a negative impact on Erectile Function recovery after radical prostatectomy? Urology 194:327\u2013332. https:\/\/doi.org\/10.1016\/j.urology.2024.07.052","journal-title":"Urology"},{"key":"3454_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2023.03.002","volume":"91","author":"G Papavasileiou","year":"2023","unstructured":"Papavasileiou G, Tsilingiris D, Spyrou N et al (2023) Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges. Semin Cancer Biol 91:70\u201398. https:\/\/doi.org\/10.1016\/j.semcancer.2023.03.002","journal-title":"Semin Cancer Biol"},{"key":"3454_CR11","doi-asserted-by":"publisher","first-page":"334e7","DOI":"10.1016\/j.urolonc.2025.01.014","volume":"43","author":"ES Deol","year":"2025","unstructured":"Deol ES, Lehner KS, Fadel AE et al (2025) Impact of obesity on prostatectomy outcomes: Insights from a large prospectively maintained cohort. Urol Oncol 43:334e7\u2013334e15. https:\/\/doi.org\/10.1016\/j.urolonc.2025.01.014","journal-title":"Urol Oncol"},{"key":"3454_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.juro.2018.04.079","volume":"200","author":"GE Cacciamani","year":"2018","unstructured":"Cacciamani GE, Gill T, Medina L et al (2018) Impact of host factors on robotic partial nephrectomy outcomes: Comprehensive Systematic Review and meta-analysis. J Urol 200:716\u2013730. https:\/\/doi.org\/10.1016\/j.juro.2018.04.079","journal-title":"J Urol"},{"key":"3454_CR13","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.2337\/dc26-S001","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes* (2026) 16. Diabetes care in the hospital: Standards of care in diabetes-2026. Diabetes Care 49:S339\u2013S355. https:\/\/doi.org\/10.2337\/dc26-S001","journal-title":"Diabetes Care"},{"key":"3454_CR14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.jacc.2024.06.013","volume":"84","author":"WC Members","year":"2024","unstructured":"Members WC, Thompson A, Fleischmann KE et al (2024) 2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 84:1869\u20131969. https:\/\/doi.org\/10.1016\/j.jacc.2024.06.013","journal-title":"J Am Coll Cardiol"},{"key":"3454_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cgh.2023.11.002","volume":"22","author":"JG Hashash","year":"2024","unstructured":"Hashash JG, Thompson CC, Wang AY (2024) AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: Communication. Clin Gastroenterol Hepatol 22:705\u2013707. https:\/\/doi.org\/10.1016\/j.cgh.2023.11.002","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3454_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S2213-8587(20)30381-8","volume":"9","author":"FJ Pasquel","year":"2021","unstructured":"Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE (2021) Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol 9:174\u2013188. https:\/\/doi.org\/10.1016\/S2213-8587(20)30381-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3454_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/SLA.0000000000006614","volume":"281","author":"SZ Aschen","year":"2025","unstructured":"Aschen SZ, Zhang A, O\u2019Connell GM et al (2025) Association of perioperative glucagon-like peptide-1 receptor agonist use and postoperative outcomes. Ann Surg 281:600\u2013607. https:\/\/doi.org\/10.1097\/SLA.0000000000006614","journal-title":"Ann Surg"},{"key":"3454_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/wjs.12484","volume":"49","author":"Z Rashid","year":"2025","unstructured":"Rashid Z, Woldesenbet S, Khalil M et al (2025) Impact of preoperative glucagon-like peptide-1 receptor agonist on outcomes following major surgery. World J Surg 49:698\u2013707. https:\/\/doi.org\/10.1002\/wjs.12484","journal-title":"World J Surg"},{"key":"3454_CR19","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.arth.2025.07.015","volume":"40","author":"V Lee","year":"2025","unstructured":"Lee V, Durkee SM, Ponce BA et al (2025) Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes in arthroplasty: A systematic review. J Arthroplasty 40:3073\u20133079. https:\/\/doi.org\/10.1016\/j.arth.2025.07.015","journal-title":"J Arthroplasty"},{"key":"3454_CR20","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1016\/j.arth.2025.06.083","volume":"40","author":"Y-C Chan","year":"2025","unstructured":"Chan Y-C, Chuang S-H, Kuo Y-J et al (2025) The association between glucagon-like peptide-1 receptor agonists and postoperative complications after arthroplasty: A systematic review and Meta-analysis. J Arthroplasty 40:3080\u20133088e7. https:\/\/doi.org\/10.1016\/j.arth.2025.06.083","journal-title":"J Arthroplasty"},{"key":"3454_CR21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.euf.2017.02.014","volume":"4","author":"D Mitropoulos","year":"2018","unstructured":"Mitropoulos D, Artibani W, Biyani CS et al (2018) Validation of the Clavien-Dindo grading system in urology by the European Association of urology guidelines ad hoc panel. Eur Urol Focus 4:608\u2013613. https:\/\/doi.org\/10.1016\/j.euf.2017.02.014","journal-title":"Eur Urol Focus"},{"key":"3454_CR22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00345-020-03356-z","volume":"39","author":"KF Kowalewski","year":"2021","unstructured":"Kowalewski KF, M\u00fcller D, M\u00fchlbauer J et al (2021) The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery. World J Urol 39:1631\u20131639. https:\/\/doi.org\/10.1007\/s00345-020-03356-z","journal-title":"World J Urol"},{"key":"3454_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bja.2025.08.003","volume":"136","author":"H-L Wu","year":"2026","unstructured":"Wu H-L, Chen J-T, Cata JP et al (2026) Risk of perioperative cardiorespiratory complications and mortality associated with preoperative glucagon-like peptide-1 receptor agonist use in type 2 diabetes mellitus: a nationwide propensity-score matched study. Br J Anaesth 136:86\u201397. https:\/\/doi.org\/10.1016\/j.bja.2025.08.003","journal-title":"Br J Anaesth"},{"key":"3454_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/asj\/sjae241","volume":"45","author":"JE Lewis","year":"2025","unstructured":"Lewis JE, Ghogomu M, Hickman SJ et al (2025) Semaglutide and postoperative outcomes in nondiabetic patients following body contouring surgery. Aesthet Surg J 45:381\u2013386. https:\/\/doi.org\/10.1093\/asj\/sjae241","journal-title":"Aesthet Surg J"},{"key":"3454_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00464-024-11263-2","volume":"39","author":"TL Kindel","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A et al (2025) Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Endosc 39:180\u2013183. https:\/\/doi.org\/10.1007\/s00464-024-11263-2","journal-title":"Surg Endosc"},{"key":"3454_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/aje\/kwq439","volume":"173","author":"MJ Funk","year":"2011","unstructured":"Funk MJ, Westreich D, Wiesen C et al (2011) Doubly robust estimation of causal effects. Am J Epidemiol 173:761\u2013767. https:\/\/doi.org\/10.1093\/aje\/kwq439","journal-title":"Am J Epidemiol"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03454-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-03454-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03454-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:04:58Z","timestamp":1780049098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-03454-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3454"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-03454-x","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective cohort study was conducted in accordance with the principles of the Declaration of Helsinki. IRB approval was obtained with waiver of informed consent by the Program for the Protection of Human Subjects (PPHS), Institutional Review Board of the Icahn School of Medicine at Mount Sinai (Protocol No. STUDY-25-00383).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived by the Program for the Protection of Human Subjects (PPHS), Institutional Review Board of the Icahn School of Medicine at Mount Sinai due to the retrospective nature of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This manuscript contains no individual patient data, images, or identifying information. Consent to publish is not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"551"}}